KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ginkgo Bioworks Holdings (DNA) Gross Margin (2020 - 2025)

Ginkgo Bioworks Holdings filings provide 6 years of Gross Margin readings, the most recent being 55.68% for Q4 2025.

  • On a quarterly basis, Gross Margin fell 5329.0% to 55.68% in Q4 2025 year-over-year; TTM through Dec 2025 was 80.93%, a 1120.0% decrease, with the full-year FY2025 number at 83.02%, down 1698.0% from a year prior.
  • Gross Margin hit 55.68% in Q4 2025 for Ginkgo Bioworks Holdings, down from 78.95% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 108.96% in Q4 2024 to a low of 144.25% in Q1 2023.
  • Median Gross Margin over the past 5 years was 42.01% (2022), compared with a mean of 17.39%.
  • Biggest five-year swings in Gross Margin: tumbled -17259bps in 2023 and later skyrocketed 24425bps in 2024.
  • Ginkgo Bioworks Holdings' Gross Margin stood at 21.74% in 2021, then soared by 103bps to 0.56% in 2022, then skyrocketed by 17770bps to 100.0% in 2023, then increased by 9bps to 108.96% in 2024, then tumbled by -49bps to 55.68% in 2025.
  • The last three reported values for Gross Margin were 55.68% (Q4 2025), 78.95% (Q3 2025), and 89.15% (Q2 2025) per Business Quant data.